LDS/Medical Tests/Copper, Serum

Copper, Serum

Copper (Cu) is an essential component of numerous enzymes, including but not limited to cytochrome oxidase, catalase, superoxide dismutase, ALA synthase, ascorbic acid oxidase, protein-lysine 6 oxidase, dopamine monooxygenase, and tyrosinase. Therefore, Cu plays important role in various metabolic pathways, such as energy production, connective tissue formation, neurotransmitter synthesis, myelin sheath formation, melanin synthesis and antioxidant system maintenance. Adult contains approximately 100 mg of copper of which only small amount is present in biological fluids. More than 95% of copper in plasma is bound with ceruloplasmin and remainder is loosely bound to albumin. Ceruloplasmin can bind 6 – 8 atoms of copper per molecule. Dietary copper is absorbed in the small intestine. About 0.5 – 2.0 mg/day of copper is excreted into the feces via the biliary system. Therefore, severe obstructive jaundice may result in copper accumulation. A relatively small fraction of copper is excreted in urine and sweat.

Copper deficiency is manifested with demineralization of bone, anemia, and hypopigmentation of the skin. Genetic defects in the gene for Menkes P-type ATPase involved in intestinal absorption of Cu is known as Menke syndrome and is associated with copper deficiency. Mutations in the ATP7B gene that is responsible for the transportation of copper across intracellular membranes (particularly in hepatocytes) is known as Wilson disease which is characterized by excessive accumulation of copper in the liver and lenticular nucleus of brain (Hepatolenticular degeneration) and results in chronic jaundice and various neurological manifestation if untreated. Measurement of serum and urinary copper together with serum ceruloplasmin is an important part of the diagnostic investigation of Wilson disease.

  • As an aid in diagnosis of Wilson disease
  • As an aid in diagnosis of liver disease
  • Useful in monitoring preterm newborns and patients under nutritional supplementation.

Increased in:

  • Primary biliary cirrhosis
  • Primary sclerosis
  • Hemochromatosis
  • Malignant diseases
  • Thyrotoxicosis
  • Use of oral contraceptive pills
  • Estrogen therapy
  • Pregnancy

Decreased in:

  • Menkes disease
  • Malnutrition
  • Malabsorption syndrome
  • Hypoproteinemia
  • Nephrotic syndrome
  • Excessive use of zinc-containing vitamins
  • Excessive use of denture cream containing zinc

0-2 months: 0.40-1.35 mcg/mL 3-6 months: 0.40-1.50 mcg/mL 7-9 months: 0.40-1.60 mcg/mL 10-12 months: 0.80-1.70 mcg/mL 13 months-10 years: 0.80-1.80 mcg/mL > or =11 years: 0.74-1.40 mcg/mL

Inductively Coupled plasma/Mass Spectrometry (ICP/MS), Atomic spectroscopy.

Serum (STT tubes), EDTA plasma (lavender top tubes).

Discontinue nutritional supplements, vitamins and minerals for before collecting samples Avoid collecting sample for 96 hours after use of iodine-, gadolinium-, or barium- containing contrast media

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Free copper, urine copper, ceruloplasmin, RBC copper, liver function test, hemoglobin.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login